Iron Mountain Incorporated (IRM) Announces Quarterly Dividend of $0.27

Iron Mountain Incorporated (NYSE:IRM) declared a quarterly dividend on Thursday, June 6th, AnalystRatings.Net reports. Investors of record on Tuesday, June 25th will be given a dividend of $0.27 per share on Monday, July 15th. This represents a $1.08 dividend on an annualized basis and a yield of 3.16%.

Several analysts have also recently commented on the stock. Analysts at Barclays Capital reiterated an “overweight” rating on shares of Iron Mountain Incorporated in a research note to investors on Monday, May 20th. They now have a $41.00 price target on the stock.

One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Iron Mountain Incorporated presently has a consensus rating of “Buy” and an average price target of $39.92.

Iron Mountain Incorporated (NYSE: IRM) opened at 34.40 on Friday. Iron Mountain Incorporated has a 1-year low of $30.50 and a 1-year high of $39.71. The stock’s 50-day moving average is currently $37.49. The company has a market cap of $6.559 billion and a price-to-earnings ratio of 45.20.

Iron Mountain Incorporated (NYSE: IRM) last announced its earnings results on Wednesday, May 1st. The company reported $0.27 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.27. The company had revenue of $747.00 million for the quarter, compared to the consensus estimate of $761.65 million. During the same quarter in the previous year, the company posted $0.35 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. Iron Mountain Incorporated has set its FY13 guidance at $1.13-1.24 EPS. Analysts expect that Iron Mountain Incorporated will post $1.18 EPS for the current fiscal year.

Iron Mountain Incorporated is an information management services company. The Company offers records management services, data protection and recovery services, and information destruction services to address information management challenges, such as rising storage costs, litigation, regulatory compliance and disaster recovery.

Latest News

Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics  Stock Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics Stock Price
Aviat Networks  Given Daily Media Impact Rating of 0.09
Aviat Networks Given Daily Media Impact Rating of 0.09
Papa Murphy’s  Getting Somewhat Positive News Coverage, Report Shows
Papa Murphy’s Getting Somewhat Positive News Coverage, Report Shows
EXFO  Given Average Recommendation of “Hold” by Brokerages
EXFO Given Average Recommendation of “Hold” by Brokerages
Brokerages Set ANI Pharmaceuticals Inc Common Stock  Price Target at $79.00
Brokerages Set ANI Pharmaceuticals Inc Common Stock Price Target at $79.00
MediBloc [QRC20] Price Tops $0.0061 on Top Exchanges
MediBloc [QRC20] Price Tops $0.0061 on Top Exchanges


© 2006-2018 Ticker Report. Google+.